131 related articles for article (PubMed ID: 9189044)
1. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?
Wilhelmsen K; Mirel D; Marder K; Bernstein M; Naini A; Leal SM; Cote LJ; Tang MX; Freyer G; Graziano J; Mayeux R
Ann Neurol; 1997 Jun; 41(6):813-7. PubMed ID: 9189044
[TBL] [Abstract][Full Text] [Related]
2. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):911-3. PubMed ID: 8057112
[TBL] [Abstract][Full Text] [Related]
3. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.
Kurth MC; Kurth JH
Am J Med Genet; 1993 Oct; 48(3):166-8. PubMed ID: 8291573
[TBL] [Abstract][Full Text] [Related]
4. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
Smith CA; Gough AC; Leigh PN; Summers BA; Harding AE; Maraganore DM; Sturman SG; Schapira AH; Williams AC
Lancet; 1992 Jun; 339(8806):1375-7. PubMed ID: 1350805
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease.
Tanaka S; Chen X; Xia Y; Kang DE; Matoh N; Sundsmo M; Thomas RG; Katzman R; Thal LJ; Trojanowski JQ; Saitoh T; Ueda K; Masliah E
Neurology; 1998 Jun; 50(6):1556-62. PubMed ID: 9633694
[TBL] [Abstract][Full Text] [Related]
6. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
Bon MA; Jansen Steur EN; de Vos RA; Vermes I
Neurosci Lett; 1999 May; 266(2):149-51. PubMed ID: 10353349
[TBL] [Abstract][Full Text] [Related]
7. Toward identification of susceptibility genes for sporadic Parkinson's disease.
Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
Ur Rasheed MS; Mishra AK; Singh MP
Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
Singh M; Khanna VK; Shukla R; Parmar D
Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
[TBL] [Abstract][Full Text] [Related]
11. CYP2D6 polymorphism and Parkinson's disease susceptibility.
Sabbagh N; Brice A; Marez D; Dürr A; Legrand M; Lo Guidice JM; Destée A; Agid Y; Broly F
Mov Disord; 1999 Mar; 14(2):230-6. PubMed ID: 10091614
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the human mitochondrial aconitase gene (ACO2).
Mirel DB; Marder K; Graziano J; Freyer G; Zhao Q; Mayeux R; Wilhelmsen KC
Gene; 1998 Jun; 213(1-2):205-18. PubMed ID: 9630632
[TBL] [Abstract][Full Text] [Related]
13. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease.
Santt O; Baranova H; Albuisson E; Bignon YJ; Lucotte G
Eur J Neurol; 2004 Apr; 11(4):247-51. PubMed ID: 15061826
[TBL] [Abstract][Full Text] [Related]
14. Association between the oxidative polymorphism and early onset of Parkinson's disease.
Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
[TBL] [Abstract][Full Text] [Related]
15. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis.
Gough AC; Smith CA; Howell SM; Wolf CR; Bryant SP; Spurr NK
Genomics; 1993 Feb; 15(2):430-2. PubMed ID: 8449513
[TBL] [Abstract][Full Text] [Related]
16. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.
Nanko S; Ueki A; Hattori M; Dai XY; Sasaki T; Fukuda R; Ikeda K; Kazamatsuri H
Am J Med Genet; 1994 Dec; 54(4):361-4. PubMed ID: 7726209
[TBL] [Abstract][Full Text] [Related]
17. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
[TBL] [Abstract][Full Text] [Related]
18. P450 enzymes and Parkinson's disease: the story so far.
Riedl AG; Watts PM; Jenner P; Marsden CD
Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
[TBL] [Abstract][Full Text] [Related]
19. Familial Parkinson's disease and polymorphism at the CYP2D6 locus.
Mazzetti P; Le Guern E; Bonnet AM; Vidailhet M; Brice A; Agid Y
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):871-2. PubMed ID: 8021689
[No Abstract] [Full Text] [Related]
20. CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.
Harhangi BS; Oostra BA; Heutink P; van Duijn CM; Hofman A; Breteler MM
Mov Disord; 2001 Mar; 16(2):290-3. PubMed ID: 11295783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
